SAN Stock: price and insider trades · Australia

SAN is a Health Care company. Its directors and officers file their transactions with ASX. 6 insiders have disclosed 8 filings since 18 October 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Insider buying of SAN has been absent for the past year. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public.

For context, the typical company on the same exchange (median of 2,222 companies) published 3 filings over the same period, against 8 filings here.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from ASX. Past trades are no guide to future returns.